Bank of America reaffirmed their buy rating on shares of Insmed (NASDAQ:INSM – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Bank of America currently has a $40.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on INSM. Barclays raised their […]
Insmed (NASDAQ:INSM – Get Free Report) had its price objective hoisted by equities research analysts at HC Wainwright from $52.00 to $70.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 22.85% from the […]
Insmed (INSM) Prices 12 62M Share Offering at $51 50/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Insmed to Host Commercial Webinar on June 4, 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.